134 related articles for article (PubMed ID: 35772286)
21. Identification of a Covalent Importin-5 Inhibitor, Goyazensolide, from a Collective Synthesis of Furanoheliangolides.
Liu W; Patouret R; Barluenga S; Plank M; Loewith R; Winssinger N
ACS Cent Sci; 2021 Jun; 7(6):954-962. PubMed ID: 34235256
[TBL] [Abstract][Full Text] [Related]
22. Differential activities of the two closely related withanolides, Withaferin A and Withanone: bioinformatics and experimental evidences.
Vaishnavi K; Saxena N; Shah N; Singh R; Manjunath K; Uthayakumar M; Kanaujia SP; Kaul SC; Sekar K; Wadhwa R
PLoS One; 2012; 7(9):e44419. PubMed ID: 22973447
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of Withania somnifera chemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis.
Tripathi CD; Gupta R; Kushawaha PK; Mandal C; Misra Bhattacharya S; Dube A
Parasite Immunol; 2014 Jun; 36(6):253-65. PubMed ID: 24830833
[TBL] [Abstract][Full Text] [Related]
24. Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani.
Chandrasekaran S; Veronica J; Gundampati RK; Sundar S; Maurya R
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1029-37. PubMed ID: 26406482
[TBL] [Abstract][Full Text] [Related]
25. Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.
Bungau S; Vesa CM; Abid A; Behl T; Tit DM; Purza AL; Pasca B; Todan LM; Endres L
Molecules; 2021 Apr; 26(9):. PubMed ID: 33919088
[TBL] [Abstract][Full Text] [Related]
26. Preparation of Withaferin A nanoparticles extracted from Withania somnifera by the expansion of supercritical fluid solution.
Karimi M; Raofie F
Phytochem Anal; 2020 Nov; 31(6):957-967. PubMed ID: 32666662
[TBL] [Abstract][Full Text] [Related]
27. Withaferin A protects against endoplasmic reticulum stress-associated apoptosis, inflammation, and fibrosis in the kidney of a mouse model of unilateral ureteral obstruction.
Chen CM; Chung YP; Liu CH; Huang KT; Guan SS; Chiang CK; Wu CT; Liu SH
Phytomedicine; 2020 Dec; 79():153352. PubMed ID: 33007732
[TBL] [Abstract][Full Text] [Related]
28. Withaferin A inhibits cell proliferation of U266B1 and IM-9 human myeloma cells by inducing intrinsic apoptosis.
Li L; Niu B; Zhang W; Hou L; Zheng Y
Acta Biochim Pol; 2022 Mar; 69(1):197-203. PubMed ID: 35235278
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotective Effect of CR-777, a Glutathione Derivative of Withaferin A, Obtained through the Bioconversion of
Rabhi C; Arcile G; Le Goff G; Da Costa Noble C; Ouazzani J
Molecules; 2019 Dec; 24(24):. PubMed ID: 31888204
[TBL] [Abstract][Full Text] [Related]
30. Withaferin A is a potent inhibitor of angiogenesis.
Mohan R; Hammers HJ; Bargagna-Mohan P; Zhan XH; Herbstritt CJ; Ruiz A; Zhang L; Hanson AD; Conner BP; Rougas J; Pribluda VS
Angiogenesis; 2004; 7(2):115-22. PubMed ID: 15516832
[TBL] [Abstract][Full Text] [Related]
31. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
32. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
33. Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.
Sun GY; Li R; Cui J; Hannink M; Gu Z; Fritsche KL; Lubahn DB; Simonyi A
Neuromolecular Med; 2016 Sep; 18(3):241-52. PubMed ID: 27209361
[TBL] [Abstract][Full Text] [Related]
34. The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates.
Abeesh P; Guruvayoorappan C
Curr Mol Med; 2024; 24(4):404-418. PubMed ID: 37076466
[TBL] [Abstract][Full Text] [Related]
35. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
[TBL] [Abstract][Full Text] [Related]
36. Enhanced withanolide production by overexpression of squalene synthase in Withania somnifera.
Grover A; Samuel G; Bisaria VS; Sundar D
J Biosci Bioeng; 2013 Jun; 115(6):680-5. PubMed ID: 23313565
[TBL] [Abstract][Full Text] [Related]
37. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
38. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
[TBL] [Abstract][Full Text] [Related]
39. Homology modelling, molecular docking, and molecular dynamics simulations reveal the inhibition of Leishmania donovani dihydrofolate reductase-thymidylate synthase enzyme by Withaferin-A.
Vadloori B; Sharath AK; Prabhu NP; Maurya R
BMC Res Notes; 2018 Apr; 11(1):246. PubMed ID: 29661206
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog inhibitors from Withania somnifera.
Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
